Get the Stockscreener App
46.16
2.82%
1.265
After Hours:
46.17
0.005
+0.01%
Azenta Inc stock is traded at $46.16, with a volume of 597.74K.
It is up +2.82% in the last 24 hours and down -4.36% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
See More
Previous Close:
$44.90
Open:
$44.11
24h Volume:
597.74K
Relative Volume:
1.08
Market Cap:
$2.19B
Revenue:
$658.62M
Net Income/Loss:
$-155.81M
P/E Ratio:
-88.78
EPS:
-0.52
Net Cash Flow:
$40.93M
1W Performance:
+10.47%
1M Performance:
-4.36%
6M Performance:
-13.58%
1Y Performance:
-7.24%
1-Day Range:
$43.86
$46.20
1-Week Range:
$40.94
$46.20
52-Week Range:
$40.24
$69.16
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta (AZTA) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast - Lelezard
Azenta (NASDAQ:AZTA) Shares Gap UpHere's Why - MarketBeat
Azenta Inc (AZTA) Stock Price Up 9.28% on Nov 4 - GuruFocus.com
Azenta Enhances Board and Reaffirms Growth Strategy - TipRanks
Azenta Enters into Cooperation Agreement with Politan Capital - Marketscreener.com
AZTAAzenta, Inc. Latest Stock News & Market Updates - StockTitan
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value - StockTitan
Raymond James & Associates Sells 33,843 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Holdings Reduced by Conestoga Capital Advisors LLC - MarketBeat
Dimensional Fund Advisors LP Expands Portfolio with Azenta Inc A - GuruFocus.com
Azenta launches first approved long-read WGS test in US - Investing.com India
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test - StockTitan
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference C - GuruFocus.com
Genewiz From Azenta Life Sciences Celebrates 25 Years Of Advancing Scientific Discoveries At Genewiz Week Event - MSN
Azenta to Participate in the UBS MedTech, Tools and Genomics Sum - GuruFocus.com
Azenta (NASDAQ:AZTA) Sets New 52-Week LowHere's Why - MarketBeat
Allspring Global Investments Holdings LLC Buys 183,040 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta's CFO Herman Cueto sells shares worth $69,669 By Investing.com - Investing.com South Africa
Azenta, Inc. (NASDAQ:AZTA) CFO Sells $69,669.60 in Stock - MarketBeat
Azenta's CFO Herman Cueto sells shares worth $69,669 - Investing.com
Azenta (NASDAQ:AZTA) Sets New 12-Month LowTime to Sell? - MarketBeat
Millennium Management LLC Decreases Stake in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Short Interest Down 10.6% in September - MarketBeat
Direct Colony Sequencing(DCS) Market to See Booming Growth – Eurofins Genomics, Azenta Life Sciences(GENEWIZ), 1st BASE – elektrotransports.lv - Elektrotransports.lv
Metric Analysis: Azenta Inc (AZTA)’s Key Ratios in the Limelight - The Dwinnex
Truist Financial Corp Sells 14,403 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta (NASDAQ:AZTA) Reaches New 12-Month LowHere's What Happened - MarketBeat
Thrivent Financial for Lutherans Sells 88,880 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Expert Advice: Fulfilling the potential of bottom-up proteomics - Drug Discovery News
Clearbridge Investments LLC Has $29.50 Million Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
The three-year earnings decline has likely contributed toAzenta's (NASDAQ:AZTA) shareholders losses of 53% over that period - Simply Wall St
Susquehanna Fundamental Investments LLC Grows Stock Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Evercore ISI Lowers Azenta (NASDAQ:AZTA) Price Target to $50.00 - MarketBeat
Sei Investments Co. Raises Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Short Interest in Azenta, Inc. (NASDAQ:AZTA) Rises By 5.3% - MarketBeat
Azenta Selected To Provide Comprehensive Proteomic Profiling for Population Scale Personalized Medicine Project - Technology Networks
Systematic Financial Management LP Reduces Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Intech Investment Management LLC Invests $609,000 in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Financial Metrics Exploration: Understanding Azenta Inc (AZTA) Through Ratios - The Dwinnex
Envestnet Asset Management Inc. Sells 66,651 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Stock Position Increased by Callan Capital LLC - Defense World
Is Azenta Inc (AZTA) worth investing in despite its overvalued state? - US Post News
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position - Yahoo Finance UK
Rhumbline Advisers Lowers Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
IBD Rating Upgrades: AZEK Shows Improved Technical Strength - Investor's Business Daily
AstraZeneca India to launch Palivizumab in Oct 2024, stocks trade flat - BusinessLine
Vanguard Personalized Indexing Management LLC Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Hsbc Holdings PLC - Defense World
Axxcess Wealth Management LLC Cuts Holdings in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):